Effects of dioscorea modified pill on cognitive impairment of patients with VCIND: An preliminary study of proton magnetic resonance spectroscopy

National Medical Journal of China

Volumn 94, Issue 39, 2014, Pages 3075-3078

  Liu, Jinhuan ^a   Chen, Jim ^a   Tan, Zihu ^a   Yang, Qiong ^a   Lan, Hanchao ^a   Zhao, Yilin ^a   Liu, Changsheng ^a   Qui, Li ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cognition disorders; Dementia; Magnetic resonance spectroscopy

Indexed keywords

ARTICLE; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PILL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; VASCULAR COGNITIVE IMPAIRMENT NO DEMENTIA; YAM; COGNITION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

COGNITION; COGNITION DISORDERS; DEMENTIA, VASCULAR; DIOSCOREA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84920288183     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2014.39.010     Document Type: Article

References (16)

1. Solfrizzi V, Reiman E, Caselli RJ, et al. CIXD and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia[J]. Neurology, 2007, 69: 1909-1916.
2. Zhou A, Jia J. The value of the clock drawing test and the mini-mental state examination lor identifying vascular cognitive impairment no dementia[J]. Int j Geriatr Psychiatry, 2008, 23: 422-426.
3. Westman E, Wahlund EO, Foy C, et al. Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease[J]. J Alzheimers Dis, 2011, 26: 307-319.
4. Soreni N, Noseworthy MD, Cormier T, et al. Intraindividual variability of striatal (1) H-MRS brain metabolite measurements at 3 T[J]. Magn Reson Imaging, 2006, 24: 187-194.
5. Zhou Y, Qun-Xu, Qin LD, et al. A primary study of diffusion tensor imaging-based histogram analysis in vascular cognitive impairment with no dementia[J]. Clin Neuml Neurosurg, 2011, 113: 92-97.
6. De Stefano N, Filippi M, Miller D, et al. Guidelines for using proton MR spectroscopy in mullicenter clinical MS studies[J]. Neurology, 2007, 69: 1942-1952.
7. Wang Z, Zhao C, Yu L, et al. Regional metabolic changes in the hippocampus and poslerior cingulate area delected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease[J]. Acta Radiol, 2009, 50: 312-319.
8. Franczak M, Prost RW, Antuono PC, et al. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study[J]. J Comput Assist Tomogr, 2007, 31: 666-670.
9. Woo BK, Harwood DC, Melrose RJ, et al. Executive deficits and regional brain metabolism in Alzheimer's disease[J]. Int J Geriatr Psychiatry, 2010, 25: 1150-1158.
10. Stebbins GT, Nyenhuis DE, Wang C, et al. Gray matter atrophy in patients with ischemic stroke with cognitive impairment [J]. Stroke, 2008, 39: 785-793.
11. Vemuri P, Jones DT, Jack CR Jr Resting state functional MRI in Alzheimer's Disease[J]. Alzheimers Res Ther, 2012, 4: 2.
12. Giulietti G, Bozzali VI, Figura V, et al. Quantitative magnetizationg transfer provides information complementary to grey malter atrophy in Alzheimer's disease brains [J]. Neuroimage, 2012, 59: 1114-1122.
13. Westman E, Wahlund LO, Foy C, et al. Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease [J]. J Alzheimer Dis, 2011, 26: 307-319.
14. McLaren DC, Sreenivasan A, Diamond EL, et al. Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer' s disease [J]. Neurodegener Dis, 2012, 9: 176-186.
15. Griffith HR, den Hollander JA, Stewart CC, et al. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease [J]. NMR Biomed, 2007, 20: 709-716.
16. 1H-MRS changes in mild cognitive impairment and Alzheimer's disease[J]. Neurobiol Aging, 2007, 28: 1330-1339.